Navigation Links
Sosei in Medical News

Sosei Announces Start of AD 923 Phase III Studies in Europe

...OKYO, Japan, February 12 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...safety and tolerability of AD 923. In June 2006, sosei entered into an agreement with Mundipharma Interna...tional markets, excluding North America and Japan. sosei is currently evaluating its commercialisation opti...

Sosei Announces Approval to Start AD 923 Phase III Studies in Europe

... TOKYO, November 28 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...in the trial". Notes to Editors: About Sosei sosei Group Corporation is a leading international bioph...ckout system that prevents inadvertent overdosing. sosei has concluded a range of studies that confirm the ...

Sosei Announces Update on Phase I Trials for SD118

... TOKYO, November 27 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ction that lead to improved drugs. About Sosei sosei Group Corporation is a leading international bioph...s on its lead compound NSL-043 in partnership with sosei Group Corporation, a listed Japanese biopharmaceut...

Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD

...AM, England, November 15 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...o severe COPD. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com... About the NVA237 licence agreement with Novartis sosei and its co-development partner Vectura Group plc c...
Sosei in Medical Technology

Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237

...riggers $7.5m Milestones for Both Companies sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...l trigger a $7.5 million milestone payment to both sosei and Vectura. The trial is a randomised, dou... NVA237 was licensed to Novartis in April 2005 by sosei and its co-development partner Vectura. Novartis i...

Sosei Confirms the Safety of SD118 in Two Phase I Trials

... TOKYO, December 8 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...esia A reduced sense of touch. About sosei sosei Group is a leading international biopharmaceutical...

Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting

...service provider and drug development Company, and sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...nflammatory pain." Mr Shinichi Tamura, CEO sosei Group added: "We are pleased to have collaborated ...opment compound NSL-043/SD118, in partnership with sosei Co. Ltd. Both of these trials reported a successfu...

NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...lar findings. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com...VA237 and QVA149 licence agreement with Novartis sosei and Vectura Group plc concluded a global developme...st, as QVA149. Under the terms of the agreement, sosei and Vectura to date have each received $15 million...

Sosei Announces Completion of Phase III Trial for NorLevo(R)

... TOKYO, July 10 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ncy contraceptive pill (ECP) SOH-075 (NorLevo(R)). sosei acquired the exclusive distribution rights to the ...d as an essential drug by the WHO. About Sosei sosei Group is a leading international biopharmaceutical...

Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA

... TOKYO, May 22, 2007 /PRNewswire-FirstCall/ -- sosei Group Corporation , a biopharmaceutical company, t...with no significant safety issues identified. sosei has reached agreement with EU regulatory authoriti...o Phase III studies." Notes for Editors: About sosei ...
Sosei in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...icenses Antibody-Drug Conjugates Development Rights to Genentech II-88 National Cancer Institute Enters into Agreement with Illumina II-89 sosei Seeks Marketing Rights for Prostate Cancer Drug in Japan II-89 8. Focus on Select Global Players II-90 Abbott Laboratories (USA) II-90 Ae...

Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria

... Based on its cytokine modulatory activity, sosei were developing RS(+) mefloquine as AD 452 for the...es over existing treatment options." About sosei sosei Group is a leading international biopharmaceutical...

Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))

... TOKYO, October 22 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...he biopharmaceutical company, today announced that sosei Co., Ltd., its wholly owned Japanese subsidiary, h... oral emergency contraceptive for post-coital use. sosei acquired the exclusive distribution rights to the ...

WWMR, Inc. Announces Launch of New Pain Clinic Monitor

...Reckitt Benckiser/Vernalis, Durect, Rinat Neuroscience/Pfizer, Elan Pharm, Roche, Eli Lilly, Sanofi-Aventis, Endo Pharm, Schwarz, Forest Laboratories, sosei R&D, Gedeon Richter, Teikoku Seiyaku, GlaxoSmithKline, TheraQuest, Grunenthal, Vernalis, GW Pharmaceuticals, Watson Pharm, Janssen-Cilag, Wyeth Pharma...

Sosei Announces Outcome of Strategy Review

... TOKYO, May 14 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ness from NVA237/QVA149 in a few years time. - sosei is closing its Chesterford operation and sosei R&D's continuing business will relocate to London...

Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities

... Prior to Marquant, Joy's positions included: Vice President, Business Development at Nabi Biopharmaceuticals; Vice President, Business Development at sosei Co. Ltd; Commercial Director at Xenova Group Limited; member of the Pharmaceuticals and Medical Products practice at Accenture; and various roles in t...

Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome

... TOKYO, September 18 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456... potential indications." Notes to Editors: About sosei sosei Group Corporation is a leading international bioph...
Other Tags
(Date:10/20/2014)... Akron, OH (PRWEB) October 20, 2014 ... new Assisted Living Center on Oct. 14. The $11 ... amenities and services, and a cooked-to-order kitchen with full-service ... forward Akron’s premier choice for first class Assisted Living ... groundbreaking. “Our residents deserve the highest quality of care ...
(Date:10/20/2014)... Final Cut Pro X Plugin developers from Pixel Film ... FCPX filmmakers . , “Fun, cool, and simple are ... Says Christina Austin, CEO of Pixel Film Studios. “It has ... comes with all the tools needed for a full ... added style, a title screen for an introduction, two lower ...
(Date:10/20/2014)... 2014 Houston plastic surgeon Dr. ... elements of his innovative True Form Tummy Tuck® ... residents and faculty at The University of Texas ... was once a medical student. Patronella, who is a ... plastic surgery practices in Texas, The Aesthetic Center ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, BambooIndustry.com, ... has unveiled its new range of bamboo deckings ... for these natural items; they are now available at ... most people, it is hard to overstate the significance ... of attention to online services. The company’s workers are ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
Breaking Medicine News(10 mins):Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
(Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
(Date:10/15/2014)... is spreading rapidly and to an unexpected extent. The ... past and the virus shows a new disease dynamic ... For this reason, the German National Academy of Sciences ... Engineering, and the Union of the German Academies of ... Ebola epidemic today. , In the statement the academies ...
Breaking Biology News(10 mins):New report synthesizes best available science on management of moist mixed-conifer forests 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5
Other Contents